ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Ludwig Cancer Research Donates $540 Million to Six Centers

January 10, 2014

In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research

January 16, 1976

Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer

March 31, 2006

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005

To Become Effective Lobbyists, Scientists Seek Alliances With Patient Advocates

March 31, 1995

Rep. Regula To Lead House Labor, HHS; Specter Likely Senate Labor, HHS Chairman.

January 12, 2001